Skip to content
1887

Access Microbiology open research platform logo Access Microbiology

Volume 7, Issue 6

Preliminary insights into the potential role of interactions in the development of antibiotic resistance Open Access

Abstract

Interactions between environmental protists and bacteria play a crucial role in shaping bacterial survival strategies and pathogenic potential. Certain bacteria have evolved mechanisms to resist predation by protists such as , allowing them to persist intracellularly and, in some cases, enhance their virulence. We hypothesize that species may also play a role in promoting antimicrobial resistance (AMR) in amoeba-resistant bacteria. This study investigated whether enhanced AMR development in under lethal ciprofloxacin concentrations. was co-incubated with and maintained in ciprofloxacin concentrations starting at 2 µg ml, four times the planktonic MIC, which was incrementally increased as resistance emerged. The survival of the co-incubated and the development of resistance were monitored, and antimicrobial susceptibility tests were conducted using multiple antibiotics. co-incubated with in the presence of ciprofloxacin became increasingly resistant in a dose-dependent manner, with the MIC increasing from 0.5 to 20 µg ml after 17 days. Contrastingly, the naïve strain did not survive sustained exposure at 2 µg ml. Co-incubated bacteria maintained under ciprofloxacin pressure developed resistance to ciprofloxacin, chloramphenicol, azithromycin and enrofloxacin while retaining susceptibility to streptomycin and tetracycline. Co-incubation in the absence of ciprofloxacin did not promote resistance in , suggesting that the combination of extracellular drug pressure and intracellular survival is important in driving resistance. These findings indicate that intracellular survival within can significantly accelerate AMR development in under fluoroquinolone pressure. Further research into the molecular mechanisms involved is warranted to inform strategies for mitigating AMR emergence in clinical and environmental contexts.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Acanthamoeba , antimicrobial resistance , ciprofloxacin , interkingdom , microbial interactions , multidrug resistance and Pseudomonas
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000999.v3
2025-06-30
2025-07-10
Loading full text...

Full text loading...

/deliver/fulltext/acmi/7/6/acmi000999.v3.html?itemId=/content/journal/acmi/10.1099/acmi.0.000999.v3&mimeType=html&fmt=ahah

References

  1. da Silva TCB, Chaúque BJM, Benitez GB, Rott MB. Global prevalence of potentially pathogenic free-living amoebae in sewage and sewage-related environments-systematic review with meta-analysis. Parasitol Res 2024; 123:148 [View Article] [PubMed]
     [Google Scholar]
  2. Samba-Louaka A, Delafont V, Rodier M-H, Cateau E, Héchard Y. Free-living amoebae and squatters in the wild: ecological and molecular features. FEMS Microbiol Rev 2019; 43:415–434 [View Article] [PubMed]
     [Google Scholar]
  3. Henriquez FL, Mooney R, Bandel T, Giammarini E, Zeroual M et al. Paradigms of protist/bacteria symbioses affecting human health: Acanthamoeba species and Trichomonas vaginalis. Front Microbiol 2020; 11:616213 [View Article] [PubMed]
     [Google Scholar]
  4. José Maschio V, Corção G, Rott MB. Identification of Pseudomonas spp. as amoeba-resistant microorganisms in isolates of Acanthamoeba. Rev Inst Med Trop Sao Paulo 2015; 57:81–83 [View Article] [PubMed]
     [Google Scholar]
  5. Dey R, Rieger AM, Stephens C, Ashbolt NJ. Interactions of Pseudomonas aeruginosa with Acanthamoeba polyphaga observed by imaging flow cytometry. Cytometry A 2019; 95:555–564 [View Article] [PubMed]
     [Google Scholar]
  6. Rayamajhee B, Willcox MDP, Henriquez FL, Petsoglou C, Subedi D et al. Acanthamoeba, an environmental phagocyte enhancing survival and transmission of human pathogens. Trends Parasitol 2022; 38:975–990 [View Article] [PubMed]
     [Google Scholar]
  7. Mooney R, Richardson K, Rodgers K, Giammarini E, Williams R et al. Acanthamoeba as a protective reservoir for Pseudomonas aeruginosa in a clinical environment. J Hosp Infect 2024; 153:21–29 [View Article] [PubMed]
     [Google Scholar]
  8. Leong W, Poh WH, Williams J, Lutz C, Hoque MM et al. Adaptation to an Amoeba host leads to Pseudomonas aeruginosa isolates with attenuated virulence. Appl Environ Microbiol 2022; 88:e0232221 [View Article] [PubMed]
     [Google Scholar]
  9. Leong W, Lutz C, Williams J, Poh YH, Yee BYK et al. Pseudomonas aeruginosa isolates co-incubated with Acanthamoeba castellanii exhibit phenotypes similar to chronic cystic fibrosis isolates. bioRxiv 2020 [View Article] [PubMed]
     [Google Scholar]
  10. Pukatzki S, Kessin RH, Mekalanos JJ. The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc Natl Acad Sci USA 2002; 99:3159–3164 [View Article] [PubMed]
     [Google Scholar]
  11. Lelong E, Marchetti A, Simon M, Burns JL, van Delden C et al. Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model. Clin Microbiol Infect 2011; 17:1415–1420 [View Article] [PubMed]
     [Google Scholar]
  12. Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004; 17:413–433 [View Article] [PubMed]
     [Google Scholar]
  13. Gomes TS, Vaccaro L, Magnet A, Izquierdo F, Ollero D et al. Presence and interaction of free-living amoebae and amoeba-resisting bacteria in water from drinking water treatment plants. Sci Total Environ 2020; 719:137080 [View Article] [PubMed]
     [Google Scholar]
  14. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000; 406:959–964 [View Article] [PubMed]
     [Google Scholar]
  15. Gani M, Rao S, Miller M, Scoular S. Pseudomonas mendocina bacteremia: a case study and review of literature. Am J Case Rep 2019; 20:453–458 [View Article] [PubMed]
     [Google Scholar]
  16. Li H, Zhang J, Song X, Wang T, Li Z et al. Alveolar epithelial cells undergo epithelial-mesenchymal transition in acute interstitial pneumonia: a case report. BMC Pulm Med 2014; 14:67 [View Article] [PubMed]
     [Google Scholar]
  17. Fernández M, Porcel M, de la Torre J, Molina-Henares MA, Daddaoua A et al. Analysis of the pathogenic potential of nosocomial Pseudomonas putida strains. Front Microbiol 2015; 6:871 [View Article] [PubMed]
     [Google Scholar]
  18. Domalaon R, Ammeter D, Brizuela M, Gorityala BK, Zhanel GG et al. Repurposed antimicrobial combination therapy: tobramycin-ciprofloxacin hybrid augments activity of the anticancer drug mitomycin C against multidrug-resistant Gram-negative bacteria. Front Microbiol 2019; 10:1556 [View Article] [PubMed]
     [Google Scholar]
  19. Díaz Santos E, Mora Jiménez C, del Río-Carbajo L, Vidal-Cortés P. Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections. Medicina Intensiva 2022; 46:508–520 [View Article]
     [Google Scholar]
  20. Campoli-Richards DM, Monk JP, Price A, Benfield P, Todd PA et al. Ciprofloxacin. Drugs 1988; 35:373–447 [View Article]
     [Google Scholar]
  21. Vance-Bryan K, Guay DRP, Rotschafer JC. Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinet 1990; 19:434–461 [View Article] [PubMed]
     [Google Scholar]
  22. Fuursted K. Post-antibiotic effect of ciprofloxacin on Pseudomonas aeruginosa. Eur J Clin Microbiol 1987; 6:271–274
     [Google Scholar]
  23. Ojkic N, Lilja E, Direito S, Dawson A, Allen RJ et al. A roadblock-and-kill mechanism of action model for the DNA-targeting antibiotic ciprofloxacin. Antimicrob Agents Chemother 2020; 64:e02487-19 [View Article] [PubMed]
     [Google Scholar]
  24. García-Villada L, Degtyareva NP, Brooks AM, Goldberg JB, Doetsch PW. A role for the stringent response in ciprofloxacin resistance in Pseudomonas aeruginosa. Sci Rep 2024; 14:8598 [View Article] [PubMed]
     [Google Scholar]
  25. EUCAST Breakpoint tables for interpretation of MICs and zone diameters, Version 13.1; 2023 https://www.eucast.org/clinical_breakpoints
  26. CLSI Performance Standards for Antimicrobial Susceptibility Testing, 31st Edition; 2021 https://clsi.org/standards/ products/microbiology/documents/m100/
  27. Priya MR, Chacko J, Ck T, Usha M. Antibiotic resistance: an emerging threat to public health. Int J Pharmacol Clin Res 2019; 1:29–34 [View Article]
     [Google Scholar]
  28. Kurjogi MM, Kaulgud RS, Naresh P. Microbial options against antibiotic-resistant bacteria; 2020233–247
  29. Klümper U, Riber L, Dechesne A, Sannazzarro A, Hansen LH et al. Broad host range plasmids can invade an unexpectedly diverse fraction of a soil bacterial community. ISME J 2015; 9:934–945 [View Article] [PubMed]
     [Google Scholar]
  30. Hudzicki J. Kirby-bauer disk diffusion susceptibility test protocol. ASM 2009; 15:55–63
     [Google Scholar]
  31. Spagnolo F, Rinaldi C, Sajorda DR, Dykhuizen DE. Evolution of resistance to continuously increasing streptomycin concentrations in populations of Escherichia coli. Antimicrob Agents Chemother 2016; 60:1336–1342 [View Article]
     [Google Scholar]
  32. Toprak E, Veres A, Michel J-B, Chait R, Hartl DL et al. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet 2012; 44:101–105 [View Article]
     [Google Scholar]
  33. Fridman O, Goldberg A, Ronin I, Shoresh N, Balaban NQ. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 2014; 513:418–421 [View Article] [PubMed]
     [Google Scholar]
  34. Windels EM, Van den Bergh B, Michiels J. Bacteria under antibiotic attack: different strategies for evolutionary adaptation. PLoS Pathog 2020; 16:e1008431 [View Article] [PubMed]
     [Google Scholar]
  35. Wistrand-Yuen E, Knopp M, Hjort K, Koskiniemi S, Berg OG et al. Evolution of high-level resistance during low-level antibiotic exposure. Nat Commun 2018; 9:1599 [View Article] [PubMed]
     [Google Scholar]
  36. Hasan NA, Norton GJ, Virdi R, Epperson LE, Vang CK et al. Measurable genomic changes in Mycobacterium avium subsp. hominissuis after long-term adaptation in Acanthamoeba lenticulata and reduced persistence in macrophages. J Bacteriol 2021; 203: [View Article]
     [Google Scholar]
  37. Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J. Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics 2020; 10:3 [View Article] [PubMed]
     [Google Scholar]
  38. Abouelhassan Y, Garrison AT, Yang H, Chávez-Riveros A, Burch GM et al. Recent progress in natural-product-inspired programs aimed to address antibiotic resistance and tolerance. J Med Chem 2019; 62:7618–7642 [View Article] [PubMed]
     [Google Scholar]
  39. Michaux C, Ronneau S, Giorgio RT, Helaine S. Antibiotic tolerance and persistence have distinct fitness trade-offs. PLoS Pathog 2022; 18:e1010963 [View Article] [PubMed]
     [Google Scholar]
  40. Liu Y, Yang K, Zhang H, Jia Y, Wang Z. Combating antibiotic tolerance through activating bacterial metabolism. Front Microbiol 2020; 11: [View Article]
     [Google Scholar]
  41. Sulaiman JE, Lam H. Evolution of bacterial tolerance under antibiotic treatment and its implications on the development of resistance. Front Microbiol 2021; 12:617412 [View Article] [PubMed]
     [Google Scholar]
  42. Santi I, Manfredi P, Maffei E, Egli A, Jenal U. Evolution of antibiotic tolerance shapes resistance development in chronic Pseudomonas aeruginosa infections. mBio 2021; 12:e03482-20 [View Article] [PubMed]
     [Google Scholar]
  43. Jakhar R, Khichi A, Kumar D, Dangi M, Chhillar AK. Discovery of novel inhibitors of bacterial DNA gyrase using a QSAR-based approach. ACS Omega 2022; 7:32665–32678 [View Article] [PubMed]
     [Google Scholar]
  44. Goli HR, Nahaei MR, Rezaee MA, Hasani A, Samadi Kafil H et al. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran. Infect Genet Evol 2016; 45:75–82 [View Article] [PubMed]
     [Google Scholar]
  45. Goli HR, Nahaei MR, Rezaee MA, Hasani A, Kafil HS et al. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and intensive care unit isolates of Pseudomonas aeruginosa. J Infect Public Health 2018; 11:364–372 [View Article] [PubMed]
     [Google Scholar]
  46. Zhao L, Wang S, Li X, He X, Jian L. Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa. Antimicrob Resist Infect Control 2020; 9:124 [View Article] [PubMed]
     [Google Scholar]
  47. Taneja N, Mishra A, Kumar A, Verma G, Sharma M. Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region. Indian J Med Res 2015; 141:81–89 [View Article] [PubMed]
     [Google Scholar]
  48. Hassan JS, Al-Safar MA, Abdul Rhman TR. The role of DNA gyrase (gyrA) in ciprofloxacin-resistant locally isolates Pseudomonas aeruginosa in Al-Khadhmiya Teaching Hospital Baghdad, Iraq. J Pure Appl Microbiol 2019; 13:499–503 [View Article]
     [Google Scholar]
  49. Wu C-J, Chen Y, Li L-H, Wu C-M, Lin Y-T et al. Roles of SmeYZ, SbiAB, and SmeDEF Efflux systems in iron homeostasis of Stenotrophomonas maltophilia. Microbiol Spectr 2022; 10:e0244821 [View Article] [PubMed]
     [Google Scholar]
  50. Langevin AM, Dunlop MJ. Stress introduction rate alters the benefit of AcrAB-TolC efflux pumps. J Bacteriol 2018; 200:e00525-17 [View Article] [PubMed]
     [Google Scholar]
  51. Piddock LJ, White DG, Gensberg K, Pumbwe L, Griggs DJ. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000; 44:3118–3121 [View Article] [PubMed]
     [Google Scholar]
  52. Iftikhar A, Asif A, Manzoor A, Azeem M, Sarwar G et al. Mutation in pvcABCD operon of Pseudomonas aeruginosa modulates MexEF-OprN efflux system and hence resistance to chloramphenicol and ciprofloxacin. Microb Pathog 2020; 149:104491 [View Article] [PubMed]
     [Google Scholar]
  53. Badawy S, Yang Y, Liu Y, Marawan MA, Ares I et al. Toxicity induced by ciprofloxacin and enrofloxacin: oxidative stress and metabolism. Crit Rev Toxicol 2021; 51:754–787 [View Article] [PubMed]
     [Google Scholar]
  54. Lázár V, Pal Singh G, Spohn R, Nagy I, Horváth B et al. Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol 2013; 9:700 [View Article] [PubMed]
     [Google Scholar]
  55. Price LB, Vogler A, Pearson T, Busch JD, Schupp JM et al. In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob Agents Chemother 2003; 47:2362–2365 [View Article] [PubMed]
     [Google Scholar]
  56. Shelke YP, Bankar NJ, Bandre GR, Hawale DV, Dawande P. An overview of preventive strategies and the role of various organizations in combating antimicrobial resistance. Cureus 2023; 15:e44666 [View Article] [PubMed]
     [Google Scholar]
  57. Miteu GD, Achinebiri P, Raghunathan N, Sankaran S. Closing potential drivers of antimicrobial resistance: last-resort antimicrobials with the potential of being misused, the way forward – a short communication. Ann Med Surg 2023; 85:3226–3231 [View Article] [PubMed]
     [Google Scholar]
  58. Salam MdA, Al-Amin MdY, Salam MT, Pawar JS, Akhter N et al. Antimicrobial resistance: a growing serious threat for global public health. Healthcare 2023; 11:1946 [View Article]
     [Google Scholar]
  59. Mahizhchi E, Sivakumar D, Jayaraman M. Antimicrobial resistance: techniques to fight AMR in bacteria – a review. J Pure Appl Microbiol 2024; 18:16–28 [View Article]
     [Google Scholar]
  60. Tang KWK, Millar BC, Moore JE. Antimicrobial resistance (AMR). Br J Biomed Sci 2023; 80:11387 [View Article] [PubMed]
     [Google Scholar]
  61. Sandegren L. Selection of antibiotic resistance at very low antibiotic concentrations. Ups J Med Sci 2014; 119:103–107 [View Article] [PubMed]
     [Google Scholar]
  62. Deshpande JD, Joshi M. Antimicrobial resistance: the global public health challenge. Int J Stu Res 2011; 1:41–44 [View Article]
     [Google Scholar]
  63. Wang Z, Huang W, Mai Y, Tian Y, Wu B et al. Environmental stress promotes the persistence of facultative bacterial symbionts in amoebae. Ecol Evol 2023; 13:e9899 [View Article] [PubMed]
     [Google Scholar]
  64. Moore DM, Withers TR, Yu H, Trzyna W. A simple plating assay using Acanthamoeba to evaluate the effect of environmental stressors on growing and dividing cells. Proc W Va Acad Sci 2016; 88: [View Article]
     [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.000999.v3
Loading
Preliminary insights into the potential role of Acanthamoeba–Pseudomonas interactions in the development of antibiotic resistance
Access Microbiology 7, 000999.v3 (2025); https://doi.org/10.1099/acmi.0.000999.v3
/content/journal/acmi/10.1099/acmi.0.000999.v3
/content/journal/acmi/10.1099/acmi.0.000999.v3
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error